Eagle Bay Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-54
| Closed | -$4.22K | – | 477 |
|
|
2024
Q4 | $4.22K | Buy |
54
+19
| +54% | +$1.48K | ﹤0.01% | 736 |
|
|
2024
Q3 | $2.81K | Sell |
35
-19
| -35% | -$1.53K | ﹤0.01% | 1154 |
|
|
2024
Q2 | $4.47K | Sell |
54
-17
| -24% | -$1.41K | ﹤0.01% | 738 |
|
|
2024
Q1 | $6.06K | Sell |
71
-26
| -27% | -$2.22K | ﹤0.01% | 679 |
|
|
2023
Q4 | $8.29K | Sell |
97
-673
| -87% | -$57.5K | 0.01% | 558 |
|
|
2023
Q3 | $69K | Buy |
770
+151
| +24% | +$13.5K | 0.03% | 339 |
|
|
2023
Q2 | $52.7K | Sell |
619
-59
| -9% | -$5.02K | 0.03% | 353 |
|
|
2023
Q1 | $56.1K | Sell |
678
-114
| -14% | -$9.43K | 0.03% | 357 |
|
|
2022
Q4 | $62.3K | Buy |
792
+151
| +24% | +$11.9K | 0.03% | 330 |
|
|
2022
Q3 | $48K | Sell |
641
-12
| -2% | -$899 | 0.03% | 341 |
|
|
2022
Q2 | $42.6K | Buy |
653
+397
| +155% | +$25.9K | 0.03% | 396 |
|
|
2022
Q1 | $16K | Sell |
256
-66
| -20% | -$4.13K | 0.01% | 240 |
|
|
2021
Q4 | $18K | Buy |
322
+74
| +30% | +$4.14K | 0.01% | 569 |
|
|
2021
Q3 | $17K | Buy |
248
+2
| +0.8% | +$137 | 0.01% | 621 |
|
|
2021
Q2 | $18K | Buy |
+246
| New | +$18K | 0.01% | 563 |
|